SCHEMBL2606763

SCHEMBL2606763

[CH2-][NH2+][C@@H](c1ccccc1)[C@@H](C)CN1CC(C)NC(C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.40
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTR2B P41595 1/20 0.37
HTT P42858 1/20 0.37
SCARB1 Q8WTV0 1/20 0.37
OPRD1 P41143 1/20 0.36
KDM4E B2RXH2 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL438886 1.00 SIGMAR1 (0.40) SIGMAR1ALDH1A1MEN1KMT2ATP53
SCHEMBL436908 0.87 MAPK14 (0.38) SIGMAR1KMT2A
SCHEMBL436957 0.87 MAPK14 (0.38) SIGMAR1KMT2A
SCHEMBL438868 0.80 SIGMAR1 (0.49) SIGMAR1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL2608097 0.79 SIGMAR1 (0.43) SIGMAR1ALDH1A1MEN1KMT2ATP53
SCHEMBL10269493 0.79 SIGMAR1 (0.43) SIGMAR1ALDH1A1MEN1KMT2ATP53
SCHEMBL435963 0.79 POLB (0.45) ALDH1A1MEN1KMT2ACYP3A4CYP2D6
SCHEMBL435990 0.78 SIGMAR1 (0.43) SIGMAR1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL438819 0.77 POLB (0.44) ALDH1A1MEN1KMT2ACYP3A4CYP2D6
SCHEMBL16181826 0.77 SIGMAR1 (0.41) SIGMAR1ALDH1A1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120214822-A1 N-CYCLOPROPYL-3-FLUORO-5-[3-[[1-[2-[2- [(2-HYDROXETHYL)AMINO] ETHOXY]PHENYL] CYCLOPROPYL] AMINO]-2-OXO- 1 (2H)-PYRAZINYL]-4-METHYL-BENZAMIDE, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND THEIR USES ASTRAZENECA AB (SE) 2012-08-23 US disclosed
US-8163905-B2 Compounds and their uses 708 ASTRAZENECA AB (SE) 2012-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214822-A1 N-CYCLOPROPYL-3-FLUORO-5-[3-[[1-[2-[2- [(2-HYDROXETHYL)AMINO] ETHOXY]PHENYL] CYCLOPROPYL] AMINO]-2-OXO- 1 (2H)-PYRAZINYL]-4-METHYL-BENZAMIDE, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND THEIR USES H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-0, CYP3A5 SIGMAR1 209/4885ALDH1A1 243/4885MEN1 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.